Bellevue Life Sciences Acquisition Corp. Contracts & Agreements

Form of First Amendment to Subscription Agreement, by and among Bellevue Life Sciences Acquisition Corp. and the investors signatory thereto (Filed With SEC on December 23, 2024)

First Amendment to Amended and Restated Business Combination Agreement, dated as of December 20, 2024 between Bellevue Life Sciences Acquisition Corp. and OSR Holdings Co., Ltd (Filed With SEC on December 23, 2024)

Promissory Note, dated October 25, 2024, issued by OSR Holdings Co., Ltd. to Bellevue Life Sciences Acquisition Corp (Filed With SEC on October 28, 2024)

Promissory Note, dated October 16, 2024, issued by Bellevue Life Sciences Acquisition Corp. to Duksung Co., LTD (Filed With SEC on October 22, 2024)

Promissory Note, dated October 11, 2024, issued by Bellevue Life Sciences Acquisition Corp. to Jun Chul Whang (Filed With SEC on October 15, 2024)

Form of Subscription Agreement, by and among Bellevue Life Sciences Acquisition Corp. and the investors signatory thereto (Filed With SEC on October 10, 2024)

Amendment to Promissory Note, dated September 20, 2024, issued by Bellevue Life Sciences Acquisition Corp. to Josh Pan (Filed With SEC on September 24, 2024)

Amendment to Promissory Note, dated September 20, 2024, issued by Bellevue Life Sciences Acquisition Corp. to Jun Chul Whang (Filed With SEC on September 24, 2024)

Promissory Note, dated July 11, 2024, issued by Bellevue Life Sciences Acquisition Corp. to Bellevue Global Life Sciences Investors, LLC (Filed With SEC on July 16, 2024)

Amended and Restated Business Combination Agreement, dated as of May 23, 2024, between Bellevue Life Sciences Acquisition Corp. and OSR Holdings Co., Ltd (Filed With SEC on May 30, 2024)

Promissory Note, dated May 14, 2024, issued by Bellevue Life Sciences Acquisition Corp. to Bellevue Global Life Sciences Investors LLC (Filed With SEC on May 14, 2024)

Promissory Note, dated April 17, 2024, issued by Bellevue Life Sciences Acquisition Corp. to Bellevue Global Life Sciences Investors LLC (Filed With SEC on April 22, 2024)

Promissory Note, dated April 8, 2024, issued by Bellevue Life Sciences Acquisition Corp. to Bellevue Global Life Sciences Investors, LLC (Filed With SEC on April 11, 2024)

Promissory Note, dated March 8, 2024, issued by Bellevue Life Sciences Acquisition Corp. to Josh Pan (Filed With SEC on March 13, 2024)

Promissory Note, dated February 9, 2024, issued by Bellevue Life Sciences Acquisition Corp. to Jun Chul Whang (Filed With SEC on February 13, 2024)

Business Combination Agreement, dated as of November 16, 2023, between Bellevue Life Sciences Acquisition Corp. and OSR Holdings Co., Ltd (Filed With SEC on November 16, 2023)

Form of Participating Stockholder Joinder Agreement (Filed With SEC on November 16, 2023)

Form of Non-Participating Stockholder Joinder Agreement (Filed With SEC on November 16, 2023)

Incentive-Based Compensation Recovery Policy (Filed With SEC on November 16, 2023)

Promissory Note, dated November 13, 2023, issued by Bellevue Life Sciences Acquisition Corp. to Bellevue Capital Management LLC (Filed With SEC on November 16, 2023)

Amendment No. 1 to Investment Management Trust Agreement, dated as of November 10, 2023, by and between Bellevue Life Sciences Acquisition Corp. and Continental Stock Transfer &... (Filed With SEC on November 15, 2023)

Promissory Note, dated June 23, 2023, issued by Bellevue Life Sciences Acquisition Corp. to Bellevue Global Life Sciences Investors LLC (Filed With SEC on June 28, 2023)

Description of Securities (Filed With SEC on March 31, 2023)

Investment Management Trust Agreement, dated February 7, 2023, by and between the Company and Continental Stock Transfer & Trust Company (Filed With SEC on February 15, 2023)

Underwriting Agreement, dated February 9, 2023, by and between the Company and Chardan. as representative of the underwriters (Filed With SEC on February 15, 2023)

Warrant Agreement, dated February 9, 2023, by and between Continental Stock Transfer & Trust Company and the Company (Filed With SEC on February 15, 2023)

Rights Agreement, dated February 9, 2023, by and between Continental Stock Transfer & Trust Company and the Company (Filed With SEC on February 15, 2023)

Registration Rights Agreement, dated February 9, 2023, by and among the Company and certain security holders (Filed With SEC on February 15, 2023)

Amended and Restated Placement Unit Purchase Agreement, dated February 9, 2023, by and between the Company and the Sponsor (Filed With SEC on February 15, 2023)

Amended and Restated Administrative Support Agreement, dated February 9, 2023, by and between the Company and the Sponsor (Filed With SEC on February 15, 2023)

Letter Agreement regarding Sponsor Indemnification, dated February 9, 2023, executed by the Sponsor and the Company (Filed With SEC on February 15, 2023)

Stock Escrow Agreement, dated February 9, 2023, by and among the Company, the Sponsor, and Company and Continental Stock Transfer & Trust Company (Filed With SEC on February 15, 2023)

Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on January 20, 2023)

Form of Stock Escrow Agreement by and among Bellevue Life Sciences Acquisition Corp., Continental Stock Transfer & Trust Company, and Bellevue Global Life Sciences Investors, LLC (Filed With SEC on January 20, 2023)

Form of Letter Agreement regarding Sponsor Indemnification (Filed With SEC on January 20, 2023)

Form of Amended and Restated Administrative Support Agreement by and between the Registrant and Bellevue Global Life Sciences Investors LLC (Filed With SEC on January 20, 2023)

Form of Amended and Restated Placement Unit Purchase Agreement between the Registrant and Bellevue Global Life Sciences Investors LLC (Filed With SEC on January 20, 2023)

Form of Registration Rights Agreement between the Registrant and certain security holders (Filed With SEC on January 20, 2023)

Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on January 20, 2023)

Form of Rights Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on January 20, 2023)

Form of Underwriting Agreement (Filed With SEC on January 20, 2023)

Amended and Restated Administrative Support Agreement, dated November 4, 2022 by and between the Registrant and Bellevue Global Life Sciences Investors LLC (Filed With SEC on November 4, 2022)

Amended and Restated Placement Unit Purchase Agreement, dated November 4, 2022, between the Registrant and Bellevue Global Life Sciences Investors LLC (Filed With SEC on November 4, 2022)

Form of Rights Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on October 7, 2022)

Form of Underwriting Agreement (Filed With SEC on October 7, 2022)

Specimen Unit Certificate (Filed With SEC on October 7, 2022)

Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on October 7, 2022)

Specimen Rights Certificate (Filed With SEC on October 7, 2022)

Form of Letter Agreement among the Registrant and our officers, directors, Chardan Capital Markets, LLC and Bellevue Global Life Sciences Investors LLC (Filed With SEC on October 7, 2022)

Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on October 7, 2022)

Form of Registration Rights Agreement between the Registrant and certain security holders (Filed With SEC on October 7, 2022)

Amended and Restated Placement Unit Purchase Agreement, dated , 2022, between the Registrant and Bellevue Global Life Sciences Investors LLC (Filed With SEC on October 7, 2022)

Amended and Restated Administrative Support Agreement, dated , 2022 by and between the Registrant and Bellevue Global Life Sciences Investors LLC (Filed With SEC on October 7, 2022)

Form of Letter Agreement regarding Sponsor Indemnification (Filed With SEC on October 7, 2022)

Form of Stock Escrow Agreement by and among Bellevue Life Sciences Acquisition Corp., Continental Stock Transfer & Trust Company, and Bellevue Global Life Sciences Investors, LLC (Filed With SEC on October 7, 2022)

Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on May 13, 2022)

Specimen Warrant Certificate (Filed With SEC on May 13, 2022)

Administrative Support Agreement, dated April 20, 2022 by and between the Registrant and Bellevue Global Life Sciences Investors LLC (Filed With SEC on May 10, 2022)

Form of Underwriting Agreement (Filed With SEC on May 10, 2022)

Specimen Warrant Certificate (Filed With SEC on May 10, 2022)

Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on May 10, 2022)

Form of Letter Agreement among the Registrant and our officers, directors, Chardan Capital Markets, LLC and Bellevue Global Life Sciences Investors LLC (Filed With SEC on May 10, 2022)

Amended and Restated Securities Subscription Agreement, dated April 22, 2022, between the Registrant and Bellevue Global Life Sciences Investors LLC (Filed With SEC on May 10, 2022)

Placement Unit Purchase Agreement, dated April 25, 2022, between the Registrant and Bellevue Global Life Sciences Investors LLC (Filed With SEC on May 10, 2022)

Form of Registration Rights Agreement between the Registrant and certain security holders (Filed With SEC on May 10, 2022)

Form of Letter Agreement regarding Sponsor Indemnification (Filed With SEC on May 10, 2022)

Specimen Common Stock Certificate (Filed With SEC on April 29, 2022)

Specimen Warrant Certificate (Filed With SEC on April 29, 2022)

Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on April 29, 2022)

Form of Letter Agreement among the Registrant and our officers, directors, Chardan Capital Markets, LLC and Bellevue Global Life Sciences Investors LLC (Filed With SEC on April 29, 2022)

Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on April 29, 2022)

Form of Registration Rights Agreement between the Registrant and certain security holders (Filed With SEC on April 29, 2022)

Amended and Restated Securities Subscription Agreement, dated April 22, 2022, between the Registrant and Bellevue Global Life Sciences Investors LLC (Filed With SEC on April 29, 2022)

Placement Unit Purchase Agreement, dated April 25, 2022, between the Registrant and Bellevue Global Life Sciences Investors LLC (Filed With SEC on April 29, 2022)

Form of Indemnity Agreement (Filed With SEC on April 29, 2022)

Administrative Support Agreement, dated April 20, 2022 by and between the Registrant and Bellevue Global Life Sciences Investors LLC (Filed With SEC on April 29, 2022)

Form of Letter Agreement regarding Sponsor Indemnification (Filed With SEC on April 29, 2022)

Form of Stock Escrow Agreement by and among Bellevue Life Sciences Acquisition Corp., Continental Stock Transfer & Trust Company, and Bellevue Global Life Sciences Investors, LLC (Filed With SEC on April 29, 2022)

Specimen Unit Certificate (Filed With SEC on April 29, 2022)

Category

Industry

Companies

Contracts

Bellevue Life Sciences Acquisition Corp. Contracts & Agreements